Two Sigma Advisers LP decreased its holdings in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 43.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,499,900 shares of the company's stock after selling 1,918,700 shares during the period. Two Sigma Advisers LP owned about 0.18% of Keurig Dr Pepper worth $93,696,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Ashton Thomas Securities LLC purchased a new position in shares of Keurig Dr Pepper during the third quarter valued at $25,000. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Keurig Dr Pepper by 617.1% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 796 shares of the company's stock valued at $27,000 after buying an additional 685 shares during the period. Blue Trust Inc. increased its stake in shares of Keurig Dr Pepper by 312.1% during the second quarter. Blue Trust Inc. now owns 849 shares of the company's stock valued at $26,000 after buying an additional 643 shares during the period. Farmers & Merchants Investments Inc. increased its stake in shares of Keurig Dr Pepper by 51.5% during the second quarter. Farmers & Merchants Investments Inc. now owns 886 shares of the company's stock valued at $30,000 after buying an additional 301 shares during the period. Finally, Hexagon Capital Partners LLC increased its stake in shares of Keurig Dr Pepper by 105.6% during the third quarter. Hexagon Capital Partners LLC now owns 1,032 shares of the company's stock valued at $39,000 after buying an additional 530 shares during the period. Hedge funds and other institutional investors own 85.23% of the company's stock.
Keurig Dr Pepper Stock Down 0.7 %
NASDAQ KDP traded down $0.22 during trading on Friday, hitting $32.76. The company's stock had a trading volume of 4,150,310 shares, compared to its average volume of 9,224,927. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36. The company has a market cap of $44.44 billion, a PE ratio of 19.99, a P/E/G ratio of 2.50 and a beta of 0.61. The business's 50 day simple moving average is $34.31 and its 200-day simple moving average is $34.62. Keurig Dr Pepper Inc. has a fifty-two week low of $28.61 and a fifty-two week high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its earnings results on Thursday, October 24th. The company reported $0.51 EPS for the quarter, hitting analysts' consensus estimates of $0.51. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The firm had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter in the previous year, the company posted $0.48 earnings per share. The company's revenue was up 2.3% compared to the same quarter last year. On average, equities analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 EPS for the current fiscal year.
Keurig Dr Pepper Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were issued a dividend of $0.23 per share. This is an increase from Keurig Dr Pepper's previous quarterly dividend of $0.22. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.81%. Keurig Dr Pepper's payout ratio is 55.76%.
Wall Street Analyst Weigh In
KDP has been the topic of several research reports. Barclays cut their price target on Keurig Dr Pepper from $41.00 to $39.00 and set an "overweight" rating on the stock in a research note on Monday, October 28th. Evercore ISI raised Keurig Dr Pepper to a "hold" rating in a research report on Thursday, September 5th. JPMorgan Chase & Co. dropped their price objective on Keurig Dr Pepper from $41.00 to $40.00 and set an "overweight" rating on the stock in a research report on Friday, October 25th. TD Cowen raised their price objective on Keurig Dr Pepper from $35.00 to $40.00 and gave the company a "hold" rating in a research report on Thursday, September 26th. Finally, Wells Fargo & Company dropped their price objective on Keurig Dr Pepper from $43.00 to $42.00 and set an "overweight" rating on the stock in a research report on Friday, October 25th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $38.36.
View Our Latest Stock Report on Keurig Dr Pepper
Insider Buying and Selling
In related news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $32.65, for a total transaction of $2,252,850,000.00. Following the completion of the transaction, the insider now directly owns 214,443,879 shares in the company, valued at approximately $7,001,592,649.35. This trade represents a 24.34 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.00% of the company's stock.
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.